Navigation Links
Reducing HIV Transmission

Researchers report encouraging results from a follow-up study of a new drug aimed at reducing the transmission of HIV from infected mothers to their newborn children.//

Health officials estimate in 2002 about 800,000 children around the world were infected with HIV through mother-to-child transmission. More than 90 percent of these cases occurred in underdeveloped nations.

The incidence is much lower in developed countries because HIV-infected mothers are routinely treated with the anti-HIV drug zidovudine during pregnancy and labor, and their infants receive the drug during the first six weeks of life. This treatment, however, is generally considered too complicated for use in less developed countries.

In 1999, investigators, working with health professionals in Uganda, reported positive results from the use of a new drug called nevirapine when administered to infected mothers once during labor and to infants one time within 72 hours of birth. The treatment was compared to a treatment regimen with zidovudine given at labor onset and every three hours until delivery to the mother and twice daily to their infants for seven days.

The current study followed the infants up to 18 months of age. Results showed the 8.2-percent reduction in HIV transmission that was seen for infants on nevirapine at six to eight weeks in the original study was sustained at 18 months. They conclude, "This simple, inexpensive, well-tolerated regimen has the potential to significantly decrease HIV-1 perinatal transmission in less developed countries."

However, researchers say resistance to single-agent anti-HIV drugs often develops and suggests more needs to be done to prevent transmission of HIV from infected mothers to their newborn children.

Suboptimum single-agent and double-agent prophylaxis protocols no longer have a justifiable place in the front lines of the global struggle against HIV/AIDS. It is up to all of us to focus on developm ent of equitable distribution and effective use of these agents now.
'"/>




Related medicine news :

1. Reducing Lung Cancer Risk
2. Reducing the risk for type 2 diabetes
3. Reducing Medication Errors
4. Reducing Pain from Knee Surgery
5. Reducing Pain From Knee Surgery
6. Reducing The After Effects of Tonsillectomy
7. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
8. Reducing Number Of Cigarettes Not Enough
9. Drug Found Effective In Reducing Vertebral Fractures In Women
10. Reducing TB With Ultraviolet Light
11. Reducing The Risk Of Fractures After a Heart Transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology: